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Abstract Holoprosencephaly (HPE), a defect in midline patterning of the forebrain and midface,
arises ~1 in 250 conceptions. It is associated with predisposing mutations in the Nodal and
Hedgehog (HH) pathways, with penetrance and expressivity graded by genetic and environmental
modifiers, via poorly understood mechanisms. CDON is a multifunctional co-receptor, including for
the HH pathway. In mice, Cdon mutation synergizes with fetal alcohol exposure, producing HPE
phenotypes closely resembling those seen in humans. We report here that, unexpectedly, Nodal
signaling is a major point of synergistic interaction between Cdon mutation and fetal alcohol.
Window-of-sensitivity, genetic, and in vitro findings are consistent with a model whereby brief
exposure of Cdon mutant embryos to ethanol during gastrulation transiently and partially inhibits
Nodal pathway activity, with consequent effects on midline patterning. These results illuminate
mechanisms of gene-environment interaction in a multifactorial model of a common birth defect.
Introduction
Many common structural birth defects appear to arise from a complex and ill-defined combination
of genetic and environmental factors (Krauss and Hong, 2016). The notion that environmental
agents affect penetrance and expressivity of predisposing mutations is speculated to underlie many
human congenital anomalies, but has been difficult to demonstrate. Animal models are therefore
valuable, but these have been slow to emerge. Some recent successful examples are a zebrafish
model of craniofacial defects (Pdgfra mutations and fetal alcohol), and mouse models of scoliosis
(Notch pathway mutations plus hypoxia), facial clefting (Pax3 mutations plus 2,3,7,8-tetrachlorodi-
benzodioxin (TCDD)), and holoprosencephaly (Hedgehog pathway mutations and fetal alcohol)
(Hong and Krauss, 2012; Kietzman et al., 2014; McCarthy et al., 2013; Sparrow et al., 2012;
Zalc et al., 2015).
Holoprosencephaly (HPE) is a common developmental defect in midline patterning of the fore-
brain and/or midface (Muenke and Beachy, 2001). HPE occurs approximately once per 250 human
conceptions, with an associated in utero lethality of ~97% (Leoncini et al., 2008; Shiota and
Yamada, 2010). HPE is characterized by an unbroken continuum of rostroventral midline anomalies
that range from complete failure to partition the forebrain into hemispheres plus cyclopia, through
progressively less severe defects including partially partitioned forebrain, single nostril, and midface
hypoplasia (Cohen, 2006; Krauss, 2007; Muenke and Beachy, 2001).
Development of the rostroventral midline is initiated by signals derived from the prechordal plate
(PCP) (Kiecker and Niehrs, 2001; Marcucio et al., 2011). The PCP produces Sonic hedgehog
(SHH), initiating a sequence of events that progressively patterns the forebrain and midface
(Aoto et al., 2009; Cordero et al., 2004; Geng and Oliver, 2009; Kiecker and Niehrs, 2001;
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Rubenstein and Beachy, 1998; Zhang et al., 2006). HH ligands trigger signaling by binding the pri-
mary receptor Patched1 (PTCH1). In the absence of ligand, PTCH1 constrains the activity of a second
membrane protein, Smoothened (SMO). HH binding inhibits PTCH1 function, allowing SMO-depen-
dent signals to activate GLI transcription factors and pathway-specific gene expression. HH ligand
availability and signal reception are also regulated by a series of co-receptors and additional HH-
binding proteins, including CDON, BOC, GAS1, and LRP2 (Beachy et al., 2010; Kong et al., 2019;
Lee et al., 2016; Petrov et al., 2017; Willnow and Christ, 2017).
The PCP develops from the anterior primitive streak (APS) under the influence of Nodal pathway
signaling (Robertson, 2014; Schier, 2009; Shen, 2007). Therefore, the Nodal pathway is develop-
mentally upstream of the HH pathway in rostroventral midline patterning. Consistent with this con-
clusion, defective Nodal signaling at the primitive streak stage of development leads to defects in
HH signaling and HPE (Krauss, 2007). Nodal is a TGFb superfamily member and signals through a
receptor complex including the type I and type II receptors, ALK4 and Activin receptor IIA/B
(ActRIIA/B), and a GPI-linked co-receptor, TDGF1 (also called Cripto) (Robertson, 2014;
Schier, 2009; Shen, 2007). Receptor activation results in phosphorylation of the transcription factors
SMAD2 and SMAD3, and activation of genes required for PCP induction (Robertson, 2014;
Schier, 2009; Shen, 2007). Among these genes are Foxa2 and Gsc (Ang and Rossant, 1994;
Belo et al., 1998; Filosa et al., 1997). Nodal signaling also induces expression of Lefty1 and Lefty2,
which encode secreted inhibitors of the pathway that bind to TDGF1 and Nodal itself (Robert-
son, 2014; Schier, 2009; Shen, 2007).
The etiology of HPE is complex, involving both genetic and environmental risk factors
(Addissie et al., 2020; Dubourg et al., 2018; Hong and Krauss, 2018; Johnson and Rasmussen,
2010; Krauss, 2007; National Birth Defects Prevention Study et al., 2010; Muenke and Beachy,
2001; NISC Comparative Sequencing Program et al., 2018; Roessler et al., 2018;
Summers et al., 2018). Heterozygous, loss-of-function mutations in components or regulators of the
HH, Nodal, and FGF signaling pathways are associated with HPE (NISC Comparative Sequencing
eLife digest A common birth defect known as holoprosencephaly affects how the brain and
face of a fetus develop in the womb. In many cases, the condition is so severe that the fetus dies
before, or shortly after, birth. Mutations in certain genes that control how the fetus develops are
associated with holoprosencephaly. For example, mutations in components of the Hedgehog and
Nodal signaling pathways, which transmit information that help cells to become specialized, increase
the risk that a fetus will develop holoprosencephaly. Environmental factors, such as exposure to
alcohol in the womb, are also thought to contribute to this condition.
A gene known as Cdon is a component of the Hedgehog signaling pathway. In 2012, a team of
researchers reported that mice with a mutation in the Cdon gene exposed to alcohol in the womb
develop symptoms similar to holoprosencephaly in humans. Here, Hong et al. – including some of
the researchers involved in the previous work – set out to understand how Cdon and alcohol work
together to cause holoprosencephaly in the mutant mice.
First, the team exposed pregnant mice to alcohol at different times during gestation to find out
when their young were sensitive to developing holoprosencephaly. This showed that the young mice
were most sensitive in early pregnancy when the Nodal pathway was active in their growing bodies.
Further experiments found that alcohol and mutations in Cdon change Nodal signaling in cells.
Together, these findings demonstrate that exposure to alcohol in the womb works together with the
mutant form of Cdon via the Nodal signaling pathway, rather than the Hedgehog pathway, to cause
holoprosencephaly in mice.
The causes of many common birth defects are complex and difficult to distinguish at the level of
individual cases. The work of Hong et al. illuminates how multiple risk factors during pregnancy,
which may not create any problems on their own, may work together to produce birth defects in the
fetus. The findings also offer new ways to understand how exposure to alcohol in the womb affects
the fetus. Ultimately, understanding how birth defects form could lead to new strategies to prevent
them in the future.
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Program et al., 2018; Roessler et al., 2018). Epidemiology of HPE is less advanced than genetic
analyses, but among the environmental risk factors implicated is fetal alcohol exposure (Abe et al.,
2018; Cohen and Shiota, 2002; Croen et al., 2000), though this is not always observed
(Addissie et al., 2020). A full range of clinical phenotypes is seen in both sporadic and familial HPE
(Muenke and Beachy, 2001; Solomon et al., 2010). Many mutation carriers in pedigrees lack clinical
manifestation, and many apparently sporadic cases have inherited a mutation from a minimally
affected parent (Lacbawan et al., 2009; Solomon et al., 2012). It is likely, therefore, that HPE-asso-
ciated mutations are not sufficient to produce midline defects, but are the substrate on which a com-
plex landscape of genetic and/or environmental modifiers act. Statistical analysis is consistent with a
multifactorial, ‘autosomal dominant with modifier’ model, wherein the penetrance and expressivity
of a heterozygous driver mutation is graded by the modifier landscape (Dubourg et al., 2018;
Hong and Krauss, 2018; Roessler et al., 2012).
We have modeled this phenomenon in mice with high fidelity. CDON encodes a multi-functional
co-receptor, including for the HH pathway, (Lu and Krauss, 2010; Sanchez-Arrones et al., 2012).
CDON loss-of-function mutations have been identified in human HPE patients (Bae et al., 2011;
NISC Comparative Sequencing Program et al., 2018), but such variants are relatively common in
the human population. Additionally, a patient with a rare homozygous CDON mutation displayed
retinal coloboma, a mild HPE-associated eye phenotype also seen in Cdon-/- mice (Berkun et al.,
2019; Pineda-Alvarez et al., 2011; Zhang et al., 2009). Therefore, CDON mutations likely require
additional insults to contribute to HPE. Studies with mice are consistent with this conclusion. Cdon-/-
mice on a 129S6 genetic background have a subthreshold defect in HH signaling and are subject to
HPE induced by genetic and environmental modifiers; among the latter is ethanol (EtOH) (Hong and
Krauss, 2018). Cdon mutation or in utero EtOH exposure individually yielded little effect on 129S6
mice. The combination, however, synergized to inhibit HH signaling in the developing forebrain and
produced a complete spectrum of HPE phenotypes with high penetrance (Hong and Krauss, 2012).
Furthermore, fetal EtOH induced a low penetrance of HPE in C57BL/6J mice, and this was exacer-
bated by heterozygosity for Shh or Gli2 (Kietzman et al., 2014). Consistent with the notion that a
threshold of HH signaling activity is rate-limiting in midline patterning, genetic removal of one copy
of the negative pathway regulator, Ptch1, rescued 129S6 Cdon-/- mice from EtOH-induced HPE
(Hong and Krauss, 2013).
Defective HH pathway function may be a final common mechanism for all classical forms of HPE,
so these results do not prove that HH signaling is the direct synergistic target of Cdon mutation and
in utero EtOH exposure. Several lines of evidence argue that EtOH itself, rather than a consequence
of its metabolism, is the HPE-inducing teratogen (Hong and Krauss, 2017). In this study, we demon-
strate that the window of sensitivity to EtOH-induced HPE in 129S6 Cdon-/- mice is closed by embry-
onic day (E) 7.5, with the sensitivity period overlapping Nodal-mediated specification of the PCP
from the APS. Furthermore, we find that CDON interacts genetically and physically with regulators
of Nodal signaling. Finally, EtOH inhibits Activin/Nodal pathway signaling in vitro in mouse epiblast
stem cells (mEpiSCs), which have transcriptional and functional properties that resemble APS cells
(Kojima et al., 2014; Tsakiridis et al., 2014). Together these results argue that, unexpectedly, Cdon
mutation and fetal alcohol synergize to induce HPE by interfering with Nodal signaling. These results
illuminate mechanisms of gene-environment interaction in a high fidelity, multifactorial model of a
common birth defect.
Results
The window of sensitivity to EtOH-induced HPE coincides with Nodal
signaling
All studies were performed with mice on a 129S6 background and are referred to only by genotype
unless otherwise noted. Our model uses one-hour timed mating of Cdon+/- mice, allowing rigorous
identification of a window of sensitivity for EtOH’s teratogenic effects. The standard EtOH treatment
regimen involves one dose at E7.0 and a second dose four hours later. This results in a full range of
HPE phenotypes in Cdon-/- mice with overall penetrance of ~75% (Hong and Krauss, 2012). The
protocol is analogous to the original regimen developed to model fetal alcohol spectrum disorders
in C57BL/6J mice, wherein ~ 19% developed HPE phenotypes (Aoto et al., 2008; Sulik et al.,
Hong et al. eLife 2020;9:e60351. DOI: https://doi.org/10.7554/eLife.60351 3 of 24
Research article Developmental Biology Genetics and Genomics
1981). HPE phenotypes were not induced in wild type C57BL/6J mice when EtOH was administered
at E6.5 or E7.5 (Aoto et al., 2008). We have shown that EtOH is ineffective in Cdon-/- mice when
administered at E8.0 (Hong and Krauss, 2012). To further refine the temporal window of sensitivity,
we assessed the ability of EtOH to induce HPE in Cdon-/- animals when administered at E7.25 and
E7.5, with embryos examined for external HPE phenotypes at E14.0. EtOH was effective at E7.25,
but not at E7.5 (Table 1 and Figure 1).
EtOH itself is the HPE-inducing teratogen in this system (Hong and Krauss, 2017). The develop-
mental processes directly perturbed by EtOH must therefore occur: 1) during the sensitive time win-
dow; and 2) prior to EtOH clearance, even if defects in midline development occur later. When
administered at E7.0, maternal blood EtOH levels peaked at E7.25 and were no longer detectable
by ~E7.75 (Hong and Krauss, 2012). Critically, EtOH is no longer effective at E7.5, a time reported
to be prior to SHH expression and function in prechordal plate-mediated rostroventral midline pat-
terning (Echelard et al., 1993; McMahon et al., 2003). These results argue that EtOH targets pro-
cesses other than, or in addition to, HH signaling in Cdon-/- mice. Consistent with this conclusion,
the time of peak sensitivity to HPE induced by the direct SMO inhibitor, Vismodegib, was E7.5, 6–12
hr later than for EtOH (Heyne et al., 2015).
Both the window of sensitivity to EtOH and peak EtOH levels overlap with induction of the PCP
by Nodal signaling. We previously observed that expression of Foxa2 and Gsc, two Nodal target
genes that mark the APS (from which the PCP is derived), was diminished at E7.25 in EtOH-treated
Cdon-/- embryos (Hong and Krauss, 2012). Both Cdon mutation and EtOH exposure were required
for this effect. Expression of Lefty2, a direct Nodal pathway target gene, was also reduced at E7.25
specifically in EtOH-treated Cdon-/- embryos (Figure 2). Taken together, these results showed that
the synergy between Cdon mutation and in utero EtOH exposure occurred during Nodal-dependent
specification of the PCP and that reduction of Nodal target gene expression required a combination
of mutation and teratogen. The observation that loss of CDON was required for the effect suggests
that, in addition to its role as a SHH co-receptor, CDON functions earlier in development to promote
midline patterning, potentially via the Nodal pathway. In fact, Cdon expression initiates during gas-
trulation and is seen in embryonic mesoderm and ectoderm (Hong and Krauss, 2012; Mulieri et al.,
2000).
Cdon interacts genetically with Nodal pathway components
Mice with mutations resulting in complete loss of Nodal signaling gastrulate abnormally and die
early in development, but hypomorphic pathway mutants display a range of HPE phenotypes
(Andersson et al., 2006; Chu et al., 2005; Lowe et al., 2001; Nomura and Li, 1998; Schier, 2009;
Shen, 2007; Song et al., 1999). To further probe the linkage between CDON and regulation of
Nodal signaling, we assessed whether Cdon interacted genetically with Tdgf1 and Lefty2, direct pos-
itive and negative regulators of the Nodal pathway, respectively. When analyzed at E10,~14% of
Cdon-/- embryos treated with EtOH had alobar HPE and cyclopia, dying in utero by E11 (Hong and
Krauss, 2012; Hong and Krauss, 2013). When studied at E14,~70% of such embryos displayed
lobar HPE and a range of craniofacial midline phenotypes, including fused upper lip and single nos-
tril (Hong and Krauss, 2012; Hong and Krauss, 2013). To address genetic interactions between
Cdon and Nodal pathway regulators, we took advantage of the high penetrance of phenotypes at
E14 and analyzed embryos at this stage for these unambiguous, easily scored phenotypes.
Table 1. Time course of EtOH-Induced HPE in Cdon-/- Embryos
EtOH treatment: E7.25 E7.5
Saline EtOH EtOH
Phenotype* Cdon+/- Cdon-/- Cdon+/- Cdon-/- Cdon+/- Cdon-/-
Fused upper lip 0/17 2/14 0/21 13/24** 0/13 0/22
Single nostril 0/17 0/14 0/21 5/24 0/13 0/22
Proboscis 0/17 0/14 0/21 2/24 0/13 0/22
* All embryos with HPE had fused upper lip, a fraction of these showed single nostril and proboscis.
**p=0.0165 by Fisher’s two-tailed exact test, when compared to EtOH-treated Cdon+/- embryos.
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Targeted mutations in Tdgf1 and Lefty2 (Ding et al., 1998; Meno et al., 1999) were placed onto
the 129S6 genetic background and then crossed to Cdon mutants to generate double heterozy-
gotes. Offspring of intercrosses of these mice were further crossed and pregnant females were
treated with EtOH or saline as a control. Tdgf1 is essential for Nodal signaling. Lefty2 is induced in
response to Nodal signaling to provide critical negative feedback as an inhibitor of the pathway.
Since CDON and EtOH may act together at the level of Nodal signaling in HPE, we predicted that
removal of one copy of Tdgf1 would sensitize Cdon-/- embryos to EtOH-induced HPE. In contrast,
removal of one copy of Lefty2 would be predicted to rescue Cdon-/- embryos from EtOH-induced
HPE. (Null mutations in Tdgf1 and Lefty2 result in early lethality due to strong gastrulation defects
(Ding et al., 1998; Meno et al., 1999), so studying homozygous double mutants with Cdon is
impossible.) To permit the detection of sensitization by Tdgf1 heterozygosity, we used a dose of
EtOH which we previously reported gives ~30% penetrance of HPE at E14 (2.9 g/kg) (Hong and
Figure 1. Time course of EtOH-Induced HPE in Cdon-/- Embryos. Frontal views of E14.0 embryos. Treatment of
Cdon-/- embryos with EtOH at E7.25, but not E7.5, results in HPE (see Table 1 for quantification). The
Cdon-/-embryo treated with EtOH at E7.25 displays a fused upper lip and single nostril (black arrow), whereas the
Cdon-/-embryo treated with EtOH at E7.5 does not and resembles the saline control (red arrow).
Figure 2. Defective Expression of Lefty2 at the Primitive Streak Stage of EtOH-Treated Cdon-/- Embryos. Whole
mount in situ hybridization analyses of Lefty2 in embryos of the indicated genotype and treatment harvested at
E7.25. Lefty2 expression was decreased specifically in EtOH-treated Cdon-/- embryos. Numbers of embryos with
similar results: Cdon+/- (saline) = 6; Cdon+/- (EtOH) = 4; Cdon-/- (saline) = 9; Cdon-/- (EtOH) = 9. Scale Bar, 200 mm.
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Krauss, 2012). With this regimen, 28% of EtOH-treated Cdon-/-;Tdgf1+/+ embryos had HPE,
whereas 55% of Cdon-/-;Tdgf1+/- embryos did (p<0.014) (Table 2 and Figure 3). With the exception
of a single EtOH-treated Cdon+/-;Tdgf1+/- embryo, EtOH-treated mice of other genotypes and
saline-treated control mice did not display HPE. Removal of one copy of Tdgf1 therefore sensitized
Cdon-/- mice to EtOH-induced HPE.
Nodal-/- and Lefty2-/- embryos have opposite defects in gastrulation and display dosage-depen-
dent genetic interactions, with Lefty2 functioning as a negative regulator of the pathway
(Meno et al., 1999). To test for phenotypic suppression in EtOH-induced HPE, we used the standard
dose of EtOH (3.48 g/kg) for these analyses, as it results in high penetrance. All embryos with HPE
at E14 display a fused upper lip, while only some show the more severe single nostril phenotype.
Approximately 70% of EtOH-treated Cdon-/-;Lefty2+/+ embryos had a fused upper lip, similar to our
previous findings (Hong and Krauss, 2012; Hong and Krauss, 2013), whereas 54% of Cdon-/-;
Lefty2+/- embryos did, revealing a trend toward overall reduction of HPE frequency (p=0.14). How-
ever, while 21% of EtOH-treated Cdon-/-;Lefty2+/+ embryos had a single nostril, only 6% of Cdon-/-;
Lefty2+/- embryos did (p=0.04) (Table 3 and Figure 4 ). Again, EtOH-treated mice of other geno-
types and saline-treated control mice did not display HPE. Therefore, removal of one copy of Lefty2
rescued a more severe form of HPE associated with EtOH treatment. Taken together, these studies
revealed that the Nodal signaling components Tdgf1 and Lefty2 act as heterozygous enhancer and
suppressor genes, respectively, of EtOH-induced HPE in Cdon-/- embryos.
EtOH inhibits Activin/Nodal signaling in mEpiSCs
The APS is a small, transiently existing cell population, making it hard to study directly. Cultured
mEpiSCs have transcriptional and functional properties resembling APS cells (Kojima et al., 2014;
Tsakiridis et al., 2014), making them a tractable in vitro surrogate model. mEpiSCs rely on FGF2
and Activin/Nodal signaling for maintenance as self-renewing, pluripotent stem cells (Brons et al.,
2007; Vallier et al., 2009). Activin A and Nodal use the same receptor and signaling mechanism,
except that Nodal, but not Activin A, requires the co-receptor TDGF1. Therefore, we evaluated the
effects of EtOH on Activin/Nodal signaling in mEpiSCs.
A direct readout of Nodal signaling activity is receptor-mediated phosphorylation of SMAD2 at
its C-terminus (Robertson, 2014; Schier, 2009; Shen, 2007). We assessed C-terminally phosphory-
lated SMAD2 (p-SMAD2C) and total SMAD2 levels in the mEpiSC line, EpiSC9 (Najm et al., 2011),
after treatment with EtOH for 6 hr. A relatively short treatment duration was chosen because: 1) the
in vivo model is an acute exposure regimen; 2) the window of sensitivity to EtOH-induced HPE
is <12 hr; and 3) high EtOH levels last only about 10 hr in pregnant females (Hong and Krauss,
2012). EtOH dose-dependently diminished p-SMAD2C levels in mEpiSCs, without altering total
SMAD2 levels (Figure 5A,B).
EtOH stimulates activation of the MAP kinase, JNK, in specific cell types (McAlhany et al., 2000;
Ren et al., 2017). SMAD2 is phosphorylated in its linker region by MAP kinases (Massague, 2003;
Rezaei et al., 2012), usually leading to inhibition of SMAD2 function (Grimm and Gurdon, 2002;
Table 2. Tdgf1 Heterozygosity Enhances EtOH-Induced HPE in Cdon-/- Embryos.
Treatment Genotype (# embryos with HPE/total (%))*
Cdon+/-;Tdgf1+/- Cdon-/-;Tdgf1+/+ Cdon-/-;Tdgf1+/-
Saline 0/23 (0%) 0/11 (0%) 2/27 (7.4%)
EtOH (2.9 g/kg) 1/48 (2.1%) 9/32 (28.1%) 31/56 (55.4%)**






No HPE was found in offspring genotypes other than those shown.
** p=0.014 by Fisher’s two-tailed exact test, when compared to EtOH-treated Cdon-/-; Tdgf1 +/+ embryos.
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Kretzschmar et al., 1999; Lessard et al., 2018). We therefore assessed total and phosphorylated
(activated) forms of JNK1 MAP kinase in EtOH-treated mEpiSCs. EtOH dose-dependently increased
phospho-JNK1 (T183/Y185) levels (p-JNK1; Figure 5A,B). Consistent with EtOH-induced p-JNK1
activation, phosphorylation of the SMAD2 linker region (p-SMAD2L) also occurred in an EtOH dose-
dependent manner, with production of p-JNK1 and p-SMAD2L correlating well (Figure 5A,B).
Human embryonic stem cells (hESCs) resemble mEpiSCs (Pauklin and Vallier, 2015). Treatment
of hESC or mEpiSC cultures with the ALK4 inhibitor, SB43152, led to reduction of Activin/Nodal tar-
get gene expression and, eventually, induction of early markers of neuroectoderm differentiation
(Chng et al., 2010; Li et al., 2015; Liu et al., 2018; Vallier et al., 2009). These studies generally
used time courses of days to weeks, but Vallier et al. assessed expression of five Activin/Nodal tar-
get and/or pluripotency-related genes in hESCs treated with SB43152 for 6 hr, the same amount of
time we treated mEpiSCs with EtOH. Levels of Nanog, Nodal, and LeftyA mRNA were reduced by
SB43152, whereas levels of Pou5f1 (also called Oct4) and Sox2 underwent little or no change
(Vallier et al., 2009). We assessed expression of these five genes in mEpiSCs treated with EtOH for
6 hr (Figure 5C). Similar to SB43152-treated hESCs, EtOH-treated mEpiSCs displayed significantly
reduced levels of Nanog and Nodal mRNAs, while Pou5f1 and Sox2 mRNA levels were largely
unchanged. Expression of the additional SB43152-inhibitable mEpiSC markers Fgf5 and T (Liu et al.,
2018) were also reduced by EtOH treatment (Figure 5C). In contrast, EtOH did not alter levels of
Figure 3. Tdgf1 Heterozygosity Enhances EtOH-Induced HPE in Cdon-/- Embryos. Frontal views of E14.0 embryos. Removal of one copy of Tdgf1
enhanced the response of Cdon-/- embryos to a dose of 2.9 g/kg EtOH (see Table 2 for quantification). The EtOH-treated Cdon-/-;Tdgf1+/- embryo
displays a fused upper lip (arrow).
Table 3. Lefty2 Heterozygosity Supresses EtOH-Induced HPE in Cdon-/- Embryos.
Treatment Genotype (# affected/total (%))*
Total HPE Single nostril
Cdon-/-;Lefty2+/+ Cdon-/-;Lefty2+/- Cdon-/-;Lefty2+/+ Cdon-/-;Lefty2+/-
Saline 1/12 (8.3%) 0/10 (0%) 0/12 (0%) 0/10 (0%)
EtOH (3.48 g/kg) 33/47 (70.2%) 26/48 (54.2%) 10/47 (21.3%) 3/48 (6.3%)**






No HPE was found in offspring genotypes other than those shown.
**p=0.04 by Fisher’s two-tailed exact test, when compared to EtOH-treated Cdon-/-;Lefty2+/+ embryos with a single nostril.
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Lefty1 or Lefty2 in mEpiSC cultures (Figure 5—figure supplement 1). As these are known Activin/
Nodal target genes, this result might be related to differences in SB43152 vs. EtOH treatment, or
differences in half-lives of these mRNAs in human vs. mouse cultures. Therefore, acute EtOH treat-
ment of mEpiSCs resulted in an inhibitory SMAD2 phosphorylation pattern and changes in gene
expression similar to those induced by a direct Activin/Nodal pathway inhibitor. Induction of neuro-
ectoderm-specific genes (e.g., Hoxa1, Six1, and Gbx2) was observed in hESCs treated with SB43152
for 2–6 days (Chng et al., 2010; Vallier et al., 2009). After 6 hr of EtOH treatment, we found a var-
ied response, with Hoxa1 levels strongly induced, Six1 expression displaying a biphasic dose-
response, and Gbx2 levels reduced (Figure 5—figure supplement 1).
Cdon and Lrp2 genetically interact in mice to generate phenotypes
resembling Nodal pathway hypomorphs, and both bind to TDGF1
Our findings argue that CDON plays an earlier role in development than its known function as a
SHH co-receptor. The need for EtOH exposure to reveal this role suggests that CDON’s effects in
primitive streak embryos may be redundant with other factors. The HH co-receptors BOC and GAS1
are not likely to be such factors, as Cdon;Boc;Gas1 triple knockout mice had a phenotype that is
close to a complete loss of embryonic HH pathway function, but not Nodal pathway-like phenotypes
(Allen et al., 2011). LRP2 is an endocytic and auxiliary receptor for multiple morphogenetic ligands
and receptors (Willnow and Christ, 2017). Lrp2-/- mice have HPE of variable penetrance and severity
(Christ et al., 2012; Spoelgen et al., 2005; Willnow and Christ, 2017; Willnow et al., 2012). We
therefore constructed mice with mutations in Cdon and Lrp2. Some Cdon;Lrp2 double mutants at
E11.5 had a severe truncation of anterior head and face structures, a phenotype neither single
mutant displayed (Figure 6A). Double-mutant embryos studied at several stages displayed a range
of phenotypes, including milder craniofacial truncation and strong HPE (Figure 6B,C). Of 30 Cdon;
Lrp2 double mutants scored between 20 and 37 somites, 24 (80%) had HPE and 6 (20%) displayed
anterior truncations. Loss of anterior head structure is a more severe phenotype than that seen even
in Smo mutants, which lack all HH signaling (Zhang et al., 2001). These phenotypes – anterior trun-
cations and HPE – are similar to those observed in mice with partial loss of Nodal pathway function
(e.g., hypomorphic Nodal and Tdgf1 mutants, and Nodal+/-;Smad2+/- mutants, each have pheno-
types that include truncation of anterior head structures and severe HPE) (Andersson et al., 2006;
Chu et al., 2005; Lowe et al., 2001; Nomura and Li, 1998; Song et al., 1999). The Cdon/Lrp2
genetic interaction is specific and selective: the Cdon paralog Boc is not expressed in primitive
streak-stage embryos (Mulieri et al., 2002; Zhang et al., 2001), and Boc mutant mice do not syner-
gize with Lrp2 mutants (unpublished results), nor are they sensitive to EtOH-induced HPE (Hong and
Krauss, 2012).
Figure 4. Lefty2 Heterozygosity Suppresses EtOH-Induced HPE in Cdon-/- Embryos. Frontal views of E14.0 embryos. Removal of one copy of Lefty2
suppressed formation of single nostril in Cdon-/- embryos in response to a dose of 3.48 g/kg EtOH (see Table 3 for quantification). The EtOH-treated
Cdon-/- embryo displays a fused upper lip and single nostril (black arrow), whereas the EtOH-treated Cdon-/-;Lefty2+/- embryo has a fused upper lip and
two nostrils (red arrow).
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CDON is a multifunctional co-receptor and promotes HH-independent signaling when associated
with various other receptors and cell adhesion molecules. In addition to binding HH ligands and
PTCH1, CDON interacts with and influences signaling by classical cadherins; the Netrin receptor,
Neogenin; and the WNT co-receptor, LRP6 (Bae et al., 2011; Bae et al., 2009; Izzi et al., 2011;
Jeong et al., 2014; Kang et al., 2003; Kang et al., 2004; Lu and Krauss, 2010; Tenzen et al.,
2006). We hypothesized that CDON might work similarly in Nodal signaling. To address this possi-
bility, we assessed whether CDON binds to Nodal receptor components. A secreted CDON ectodo-
main fused in-frame at its carboxy terminus with the IgG Fc region (CDON-Fc) was expressed in
Figure 5. Acute EtOH treatment inhibits activin/nodal signaling in mEpiSCs. (A) Representative western blot of mEpiSCs treated with the indicated
doses of EtOH for 6 hr. GAPDH was used as a loading control. (B) Densitometric quantification of p-SMAD2C levels, relative to total Smad2; p-JNK1
levels, relative to total JNK1; and p-SMAD2L levels, relative to total SMAD2, with the indicated doses of EtOH. N = 3 experiments with two biological
replicates (as shown in (A)) in each experiment. (C) qRT-PCR analysis of Nanog, Nodal, Pou5f1, and Sox2 expression in mEpiSCs treated with the
indicated doses of EtOH for 6 hr. Expression was normalized to Gapdh expression. N = 3 experiments with two biological replicates in each
experiment. Values for (B) and (C) are means ± SEM, *p<0.05, **p<0.01, ***p,0.001 by Student’s t-test.
The online version of this article includes the following source data and figure supplement(s) for figure 5:
Source data 1. Source data for quantification of western blot results shown in Figure 5A and B.
Source data 2. Source data for quantification of qRT-PCR results shown in Figure 5C.
Figure supplement 1. Analysis of gene expression in EtOH-treated mEpiSCs.
Figure supplement 1—source data 1. Source data for quantification of qRT-PCR results shown in Figure 5.
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HEK293T cells with individual ectodomains of the Nodal receptor (ActRIIA, ActRIIB, ALK4, and
TDGF1) fused in-frame at their carboxy termini with alkaline phosphatase (AP). As positive and nega-
tive controls, SHH-N-AP and CD164-AP were used, respectively (SHH-N is the active portion of SHH,
CD164 is a cell surface sialomucin) (Kang et al., 2002; Tenzen et al., 2006). The use of secreted
Figure 6. Cdon and Lrp2 Interact Genetically to Produce HPE and Anterior Truncations in Mice. (A) Whole mount E11.5 embryos of the indicated
genotype. Note the loss of anterior head structures in the Cdon-/-;Lrp2-/- embryo (arrow). (B) E18.5 embryos of the indicated genotype in whole mount
and alizarin red/alcian blue-stained skeleton preparations. Note the craniofacial truncation in the Cdon-/-;Lrp2-/- embryos (arrows). (C) Whole mount P0
Cdon-/-;Lrp2-/- embryo showing severe HPE.
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ectodomains reduces the possibility that unknown, cell surface-bound factors promote binding or
contribute directly to the complex. Conditioned medium was collected, and equivalent amounts of
AP fusion proteins from conditioned media were pulled down and blotted for captured CDON-Fc.
Conversely, equivalent levels of Fc were pulled down, and associated AP activity was quantified.
Similar results were obtained in each pull-down: CDON-Fc interacted efficiently with TDGF1-AP, sim-
ilar to the interaction between CDON-Fc and SHH-N-AP (Figure 7A,B). CDON-Fc did not bind to
the negative control CD164-AP, and it interacted only weakly with the AP-tagged versions of ALK4,
ActRIIA, and ActRIIB (Figure 7A,B).
As CDON and LRP2 interacted genetically to produce Nodal hypomorph-like phenotypes, we
asked whether LRP2, like CDON, binds to TDGF1. The extracellular region of LRP2 harbors four
repetitive modules, each comprising a cluster of complement-type repeats followed by EGF-type
repeats and b-propellers. Each module is likely capable of independently binding ligands, as shown
for the related receptor, LRP1 (Croy et al., 2003). LRP2 is a huge polypeptide of 4660 amino acids,
making it difficult to express in vitro. Therefore, we constructed a series of soluble ‘mini-receptors’
(designated sR1, sR2, sR3, and sR4) spanning virtually the entire ectodomain in four non-overlapping
pieces, each fused in-frame at their carboxy termini to the IgG Fc region (see Figure 7C). Each solu-
ble ectodomain segment and TDGF1-AP were expressed in HEK293T cells and assessed for their
ability to bind to each other. LRP2 binds SHH-N (Christ et al., 2012; McCarthy et al., 2002), so this
ligand was used again as a positive control, with CD164-AP serving as a presumptive negative con-
trol. Each soluble LRP2 mini-receptor ectodomain (i.e., sR1 to sR4) pulled down SHH-N-AP, revealing
that LRP2 harbors multiple SHH-N binding sites (Figure 7D). These results were confirmed by
expressing each ectodomain segment joined with the native LRP2 transmembrane and cytoplasmic
domains (mini-receptors R1, R2, R3, and R4; Figure 7C) in NIH3T3 cells. These cultures were incu-
bated with recombinant SHH-N-GST fusion proteins for 2 hr, followed by immunoprecipitation with
anti-LRP2 antibody recognizing all mini-receptors and western blotting with antibodies to LRP2 or
GST. Again, all four mini-receptors pulled down SHH-N, whereas no pulldown of SHH-N was seen in
control transfectants lacking LRP2 mini-receptors (Figure 7—figure supplement 1). Finally, we
assessed LRP2 binding to TDGF1 with the soluble ectodomain binding assay. Similar to its multiva-
lent interaction with SHH-N, the soluble LRP2 ectodomain segments sR3 and sR4 pulled down
TDGF1-AP (Figure 7D). Soluble LRP2 ectodomain segments sR1 and sR2 also pulled down TDGF1-
AP, but greater variability in the interaction was observed, leading to p>0.05 (p=0.14 and p=0.06,
respectively). The efficiency of LRP2 mini-receptor ectodomains to bind SHH-N-AP and TDGF1-AP
was similar to that of CDON-Fc (Figure 7D).
Discussion
HPE is a common developmental disorder, but its etiology remains poorly understood. Mutations in
the Nodal, HH, and FGF pathways are associated with HPE (NISC Comparative Sequencing Pro-
gram et al., 2018), but these alone are insufficient to drive aberrant development. Identifying and
understanding the critical phenotypic modifiers of such mutations is important but still in its infancy.
Many birth defects are thought to be caused by poorly defined interactions between genetic and
environmental risk factors, but the mechanistic bases of these interactions are largely unknown
(Krauss and Hong, 2016). Cdon mutation and fetal alcohol are each implicated in human HPE
(Abe et al., 2018; Bae et al., 2011; Cohen and Shiota, 2002; Croen et al., 2000;
NISC Comparative Sequencing Program et al., 2018), though neither may be sufficient. The Cdon
mutation plus fetal alcohol model is noteworthy for its specificity and fidelity to many aspects of
human HPE (Hong and Krauss, 2012). Therefore, illumination of how loss of Cdon interacts with in
utero EtOH exposure provides insight into mechanisms of HPE and how fetal alcohol functions as a
teratogen.
The Nodal pathway is developmentally upstream from the HH pathway in patterning the rostro-
ventral midline. While CDON is clearly a component of the HH pathway, it regulates signaling within
several additional pathways as well (Bae et al., 2011; Bae et al., 2009; Izzi et al., 2011;
Jeong et al., 2014; Kang et al., 2003; Kang et al., 2004; Lu and Krauss, 2010; Tenzen et al.,
2006). Multiple lines of evidence presented here argue that CDON also regulates Nodal signaling
and that the Nodal pathway is a major point of synergistic interaction between mutation of Cdon
and fetal EtOH exposure. The evidence includes: (1) EtOH-treated Cdon-/- embryos display defects
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Figure 7. CDON and LRP2 Bind to TDGF1. (A) The indicated AP-tagged proteins were co-expressed with CDON-Fc, and equivalent amounts of AP
proteins in conditioned medium (CM) were pulled down. Levels of CDON-Fc in CM and in the pull down were detected by western blot. (B) CDON-Fc
was pulled down from CM derived from transfections as in (A), the amount of CDON-Fc from various CM normalized, and associated AP enzyme
activity quantified, N = 4 for (A) and (B). (C) Schematic of full length LRP2 and recombinant mini-receptor variants used. Each mini-receptor spans one
of the four repetitive modules of the extracellular receptor domain and was expressed either as soluble ectodomain fragments fused to IgG Fc
(designated sR1- sR4) or as a membrane-bound mini-receptor fused to the authentic transmembrane and intracellular domains of LRP2 (designated R1-
R4). Soluble ectodomain fragments sR1 – sR4 were studied in panel (D), whereas mini-receptors R1 – R4 were used in Figure 7—figure supplement 1 .
Amino acid numbers next to the full-length receptor polypeptide indicate the extent of individual receptor domains. (D) The indicated Fc-tagged
proteins were pulled down from CM derived from transfections as in (A), the amount of Fc-tagged protein from various CM normalized, and associated
AP enzyme activity quantified, N = 3. Values for (B) and (D) are means ± SEM, *p<0.05, **p<0.01 by Student’s t-test.
The online version of this article includes the following source data and figure supplement(s) for figure 7:
Figure 7 continued on next page
Hong et al. eLife 2020;9:e60351. DOI: https://doi.org/10.7554/eLife.60351 12 of 24
Research article Developmental Biology Genetics and Genomics
in expression of Nodal target genes in the APS (including Gsc, Foxa2, and Lefty2), whereas EtOH
treatment or Cdon mutation alone do not (Hong and Krauss, 2012; this study); (2) the window of
sensitivity to EtOH-induced HPE is very narrow and closed by E7.5, a time reported to be prior to
SHH expression and function in prechordal plate-mediated rostroventral midline patterning; (3)
EtOH itself is the likely HPE-inducing teratogen and peak circulating EtOH levels coincide with Nodal
signaling in the APS; (4) Cdon interacts genetically with the critical Nodal pathway factors Tdgf1 and
Lefty2 in EtOH-induced HPE; (5) acute EtOH treatment dose-dependently diminishes p-SMAD2C
and elevates p-SMAD2L levels, and inhibits Activin/Nodal-dependent gene expression, in mEpiSCs;
(6) Cdon;Lrp2 double mutants display phenotypes similar to mice with hypomorphic Nodal pathway
mutations, including anterior truncations, a phenotype not seen in mice lacking all HH signaling; and
(7) CDON and LRP2 both bind efficiently to TDGF1, an essential component of the Nodal receptor.
We note that although EtOH inhibited p-SMAD2C production in mEpiSCs, and diminished expres-
sion of Nodal target genes in both mEpiSCs and Cdon-/- embryos, we have not yet demonstrated
that EtOH inhibits p-SMAD2C production in embryos; additional work is therefore required to show
the mechanisms in vitro and in vivo operate at the same level. Similarly, analysis of Nodal signaling
in Cdon;Lrp2 double mutant embryos requires study.
Together our findings are consistent with the following model: CDON and LRP2 function with
overlapping or compensatory roles to regulate Nodal pathway signaling in the APS during induction
of the PCP. Brief exposure of Cdon-/- embryos to EtOH during this period transiently and partially
inhibits Nodal pathway activity. While all the mice successfully gastrulate, they emerge from this
period predisposed towards development of HPE in a stochastic manner. If HH signaling strength
fails to reach a required threshold early during rostroventral midline patterning, at the PCP stage,
the outcome is alobar HPE and cyclopia; if it occurs at later stages of development, the outcomes
are progressively less severe. Aspects of the model will require additional experimentation, but it is
logically consistent with the synergistic effects of fetal alcohol and Cdon mutation within a narrow
window of sensitivity, and also with the ‘mutation plus modifier’ view of human HPE. Our findings do
not exclude that EtOH may also target HH signaling in Cdon-/- mice, but they are consistent with
Nodal signaling being a major target of EtOH in HPE.
The specific mechanisms whereby acute EtOH treatment reduces expression of Nodal target
genes in the APS of Cdon-/- mice and diminishes Activin/Nodal signaling in mEpiSCs are not known.
EtOH itself, rather than consequences of its oxidative metabolism, is very likely the HPE-inducing
teratogen (Hong and Krauss, 2017). An alternative mechanism to metabolism-based toxicity is that
EtOH itself functions to perturb cell membranes via its hydrophobicity (Lyon et al., 1981;
McKarns et al., 1997). One possibility is that EtOH’s hydrophobic nature perturbs trafficking of
Nodal receptor components or their stable assembly at the cell surface. TDGF1 is a GPI-linked pro-
tein, so might be especially vulnerable to hydrophobic membrane perturbation. However, exoge-
nously provided Activin A is the major activator of SMAD2 in cultured mEpiSCs, and Activin does
not require TDGF1 to signal through ActRII/ALK4. EtOH reduces p-SMAD2C levels in these cultures,
so TDGF1 may not be a direct critical target of EtOH. Nevertheless, mEpiSCs endogenously express
Nodal (Kojima et al., 2014), which does require TDGF1, and its contribution to SMAD2 signaling in
these cultures is not fully clear. Additionally, EtOH activates JNK1 in mEpiSCs, with a corresponding
increase in p-SMAD2L levels. Phosphorylation of SMAD2 by MAP kinases is generally inhibitory to
SMAD2 activity, independent of p-SMAD2C phosphorylation status (Massague, 2003; Rezaei et al.,
2012), so EtOH appears to promote or inhibit multiple signals that converge on SMAD2
phosphorylation.
CDON regulates several signaling pathways, but it has not previously been implicated in Nodal
signaling. How CDON functions to regulate Nodal signaling is of obvious interest. Cdon;Lrp2 double
mutant mice display phenotypes that resemble Nodal pathway hypomorphs, and CDON and LRP2
Figure 7 continued
Source data 1. Source data for quantification of AP activity in CDON-Fc pulldown experiments shown in Figure 7B.
Source data 2. Source data for quantification of AP activity in CDON-Fc and soluble LRP2 minireceptor-Fc pulldown experiments shown in Figure 7D.
Figure supplement 1. HEK293 cell transfectants expressing the indicated LRP2 mini-receptor were incubated with GST-SHH-N, and cell lysates
immunoprecipitated with antibody to LRP2 and blotted with antibodies to LRP2 and GST.
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each bind to TDGF1. Therefore, as with the effects of EtOH, TDGF1 is a possible point of regulation.
One potential mechanism is that CDON and LRP2 might function as components of a larger Nodal
receptor complex, contributing via interaction with TDGF1. Alternatively, they may work with TDGF1
in processing and trafficking of Nodal or other receptor components, or play a role in processing
and trafficking of TDGF1 itself (Constam, 2009). There is evidence in other systems that CDON and
LRP2 can act in such a manner. LRP2 is best understood as an endocytic receptor that controls inter-
nalization and intracellular trafficking of both soluble and membrane-bound proteins, including
PTCH1, the Na+/H+ exchanger NHE3, and the intrinsic factor receptor, Cubilin (Willnow and Christ,
2017). Furthermore, CDON regulates subcellular localization of N-cadherin during neural crest
migration in zebrafish (Powell et al., 2015). Similarly, the Drosophila orthologs of CDON act not
only as co-receptors for HH, but in trafficking of the primary HH receptor, PTC (Zheng et al., 2010).
Another possibility is in regulation of cell-cell contact and adhesion. CDON is localized to sites of
cell-cell contact and functions with N-cadherin in cell adhesion-dependent signaling (Kang et al.,
2003; Lu and Krauss, 2010). In zebrafish, a positive feedback loop exists between Nodal signaling,
E-cadherin expression, and duration of cell-cell contact, that directs PCP specification at the expense
of endoderm specification (Barone et al., 2017). It is conceivable that CDON could play a role in
adhesion-mediated, higher order regulatory events like this as well. These varied potential mecha-
nisms are not mutually exclusive.
Our findings offer insight into how Cdon mutation synergizes with fetal alcohol in mice to pro-
duce a wide spectrum of HPE phenotypes, closely resembling the complex etiology and variable
outcomes seen in humans at the population level. A combination of approaches, including window
of sensitivity studies, genetic interactions in mice, and in vitro analyses revealed that, unexpectedly,
a major point of synergy is at the level of Nodal signaling. These findings illuminate gene-environ-
ment interactions in the causation of a common birth defect, expand understanding of alcohol tera-
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Mice
All animal procedures were conducted in accordance with institutional guidelines for the care and
use of laboratory animals as approved by the Institutional Animal Care and Use Committee (IACUC)
of the Icahn School of Medicine at Mount Sinai and according to Max-Delbruck-Center guidelines
following approval by local authorities (X9007/17). B6.129P2-Lefty2tm1Hmd mice were provided by
Hiroshi Hamada. Tdgf1 mutant mice (Cripto-LacZ mice) were provided by Michael Shen. Both strains
were transferred onto the 129S6/SvEvTac (129S6) background with the Taconic Speed Congenic
Program, by backcrossing and mapping with the 1450 SNP array. Mice used for these experiments
were estimated to be over 98% 129S6/SvEvTac background. These lines were crossed with Cdon+/
tm1Rsk (Cdon+/-) mice on the 129S6 background (Cole and Krauss, 2003; Hong and Krauss, 2012)
to generate 129S6.Cdon+/-;Lefty2+/- and 129S6.Cdon+/-Tdgf1+/- double mutant mice. Because Cdon
and Tdgf1 are both located on chromosome 9, Cdon+/-;Tdgf1+/- mice were crossed with wild type
mice and offspring screened for those that carried a recombinant chromosome 9 carrying both
Cdon and Tdgf1 mutant alleles. Offspring of intercrosses of these mice were further crossed (see
Tables 2 and 3 for details) and pregnant females treated with EtOH or saline as a control (Hong and
Krauss, 2012). Briefly, two- to three-month old mice were mated for one hour in the dark and
plugged females were collected. The time of the plug was designated as embryonic day (E) 0.0.
Pregnant female mice were injected intraperitoneally twice with 15 ml per g body weight of solution
of 30% EtOH in saline (3.48 g/kg) at E7.0 and again 4 hr later. For window-of-sensitivity experiments,
pregnant females were treated similarly, except the initial dose was given at E7.25 or E7.5. For stud-
ies involving Cdon;Tdgf1 mutants, a lower dose of ethanol (25% EtOH in saline, 2.9 g/kg) was used.
Saline injections were used as controls throughout.
Mice with targeted gene disruption of Lrp2 (Lrp2tm1Her) have been described (Willnow et al.,
1996). Lrp2+/tm1Her (Lrp2+/-) mice were kept on the C57BL/6N genetic background and crossed with
Cdon+/- mice on the C57BL/6N genetic background. Offspring were further intercrossed, and
Lrp2+/-;Cdon+/- mice were subjected to timed mating to collect embryos at the depicted embryonic
day. Neither Cdon-/- mice nor Lrp2-/- mice on the C57BL/6N display anterior truncation phenotypes.
Whole mount in situ hybridization
Whole mount RNA in situ hybridization was performed according to standard protocols (Hong and
Krauss, 2012). Briefly, embryos were dissected out and fixed in 4% paraformaldehyde in phosphate-
buffered saline (PBS), dehydrated through a graded methanol series, and stored at  20˚C. Rehy-
drated embryos were treated with 10 mg/ml proteinase K (Qiagen) in PBS, 0.1% Tween-20 (PBST)
according to stage. Embryos were rinsed with PBST, post-fixed and hybridized with digoxygenin
(DIG)-labeled probe in hybridization mix (50% formamide, 1.3x SSC pH 5.0, 5 mM EDTA, 50 mg/ml
yeast tRNA, 100 mg/ml heparin, 0.2% Tween-20, and 0.5% CHAPS) overnight at 65˚C. They were
washed, blocked with 2% Roche blocking reagent, 20% heat-inactivated lamb serum in Tris-buffered
saline with 0.1% Tween-20 (TBST) and incubated with alkaline phosphate-conjugated anti-DIG anti-
body (1:2000, Roche) in blocking buffer overnight at 4˚C. After washing with TBST and NTMT (100
mM NaCl, 100 mM Tris pH9.5, 50 mM MgCl2, and 0.1% Tween-20), embryos were stained with BM
Purple AP substrate (Roche) in the dark. Stained embryos were cleared in 80% glycerol and photo-
graphed with a Jenoptik ProgRes C3 camera attached to Nikon SMZ 1500 stereomicroscope. Cap-
tured images were assembled by Helicon Focus software (Helicon Soft).
Mouse epiblast stem cell culture and western blot and qRT-PCR analysis
Mouse epiblast stem cells (EpiSC9 cells) were obtained from Jianlong Wang, authenticated by
robust expression of pluripotency markers, and confirmed to be negative for mycoplasma infection.
EpiSC9 cells were cultured as described (Huang et al., 2017). Briefly, cells were cultured on 0.1%
fibronectin-coated plates (MilliporeSigma, 10 mg/ml/cm2) in N2B27 media supplemented with 20 ng/
ml Activin A (R and D Systems) and 12 ng/ml Fgf2 (R and D Systems). Media were changed daily.
EpiScs were treated with EtOH for six hours in fresh EpiSC media with supplements. For protein
analysis, cells were harvested with RIPA buffer plus protease inhibitor (Sigma) and phosphatase
inhibitor (Sigma). Western blotting was as described (Bae et al., 2009). Images were scanned and
quantified using ImageJ software. Statistical significance was calculated using Student’s t-test and a
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cutoff of p<0.05. Primary antibodies used for western blot: SMAD2 (Cell Signaling #5339),
p-SMAD2C (Cell Signaling #3108), p-SMAD2L (Cell Signaling #3104), JNK (Cell Signaling #9252),
p-JNK (Cell Signaling #9251), and GAPDH (Cell Signaling #97166). For mRNA analysis, total RNA
was extracted from EpiSCs using the RNAeasy kit (Quiagen). Reverse transcription and cDNA pro-
duction were performed with Superscript III first strand synthesis system (Invitrogen). qPCR was per-
formed using iQ SyBR green supermix (BioRad) on an iCycler iQ5 (BioRad). Gene expression levels
were normalized to Gapdh.
Protein-protein interactions
Expression vectors encoding soluble, tagged forms of CDON, SHH-N, CD164, ActRIIA, ActRIIB,
ALK4, TDGF1, and LRP2, and LRP2 mini-receptors that encoded the LRP2 transmembrane and intra-
cellular domains, were constructed by standard methods; details are available on request. HEK293T
cells were obtained from ATCC, confirmed to be negative for mycoplasma infection, and cultured in
DMEM with 10% FBS and 1x Penicillin/Streptomycin. HEK293T cells in 10 cm dishes were transfected
with a total of either 2 or 3 mg of plasmid vectors using Effectene reagent (Qiagen). Media were
changed to 2% FBS two days after transfection. Conditioned media were harvested five days after-
wards. Soluble fusion proteins in conditioned media were quantified by dot blotting with human IgG
Fc protein (Jackson ImmunoResearch Laboratories) as a standard, and by alkaline phosphatase (AP)
enzyme activity using AP yellow liquid substrate (Sigma). For analysis of CDON-Fc interactions with
soluble AP-tagged proteins, the factors were coexpressed in HEK293T cells. For Fc pull down and
AP activity assays with CDON-Fc, soluble fusion proteins were incubated with protein G agarose
beads (Roche) for 2 hr at 4˚C. For analysis of soluble LRP2-Fc mini-receptors interactions with soluble
AP-tagged proteins, LRP2 sR1-sR4 and the AP-tagged counterparts were generated separately in
individual transfections and CM mixed together. Pull down complexes were washed five times with
ice-cold HNTG buffer (20 mM HEPES pH 7.5, 150 mM NaCl, 0.1% Triton X-100, 10% glycerol).
Endogenous AP was inactivated by heat inactivation. AP activity in pull-down complexes was mea-
sured using AP yellow liquid substrate (Sigma). For AP pull down followed by western blot analysis,
soluble fusion proteins were incubated with anti-AP conjugated agarose beads (Sigma) overnight at
4˚C. Pull-down complexes were washed five times with HNTG buffer, eluted from the beads by boil-
ing, and separated by SDS-PAGE. Antibodies used for western blot were HRP conjugated with goat
anti-human Fc.
To test SHH-N interaction with membrane-bound LRP2 mini-receptors, NIH3T3 cells were trans-
fected with the four individual LRP2 mini-receptors encoding transmembrane and intracellular
domains and incubated with 20 mg/ml GST-SHH-N in the medium for two hours. Cell lysates were
immunoprecipitated with polyclonal LRP2 antibody directed against full-length LRP2, and subjected
to western blot analysis with anti-LRP2 and anti-GST antibodies.
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